Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.
Open | $2.55 |
Close | $2.55 |
Volume / Avg. | 469.06K / 248.87K |
Day Range | $2.45 - $2.67 |
52 Wk Range | 1.66 - 6.80 |
Market Cap | $140.31M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 14.04% |
Days to Cover | 10.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Adverum Biotechnologies (NASDAQ:ADVM), Citius Oncology (NASDAQ:CTOR) and Adicet Bio (NASDAQ:ACET).
There is no analysis for Prelude Therapeutics to provide a consensus price target.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $2.55 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.